Curriculum content for management of common and uncommon RMD conditions
| Condition | N (% schools) |
| Osteoarthritis | 20 (95.2%) |
| Chronic back pain | 18 (85.7%) |
| Nerve root entrapment | 19 (90.5%) |
| Fibromyalgia | 17 (81%) |
| Osteoporosis including primary preventions | 20 (95.2%) |
| Gout including treatment to target | 20 (95.2%) |
| CPP deposition disease | 16 (76.2%) |
| Apatite crystal deposition | 13 (61.9%) |
| Rheumatoid arthritis | 20 (95.2%) |
| Spondyloarthritis | 20 (95.2%) |
| SLE | 21 (100%) |
| Anti-phospholipid syndrome | 19 (90.5%) |
| Systemic sclerosis | 19 (90.5%) |
| Sjögren’s syndrome* | 18 (85.7%) |
| Polymyalgia rheumatica | 21 (100%) |
| Giant cell arteritis | 19 (90.50%) |
| Systemic vasculitis | 18 (85.7%) |
| Inflammatory myopathies | 17 (81%) |
| Bone/joint infection | 19 (90.5%) |
| Osteomalacia | 16 (76.2%) |
| Osteonecrosis | 15 (71.4%) |
| Paget’s disease of bone | 15 (71.4%) |
*Either primary or secondary.
CPP, calcium pyrophosphate; RMD, rheumatic and musculoskeletal disease; SLE, systemic lupus erythematosus.